LD-2 disclosure · 4th Quarter - Report
INOVIO PHARMACEUTICALS, INC.
via INOVIO PHARMACEUTICALS, INC.
Client
- Name
- INOVIO PHARMACEUTICALS, INC.
- Description
- Biotechnology company
- Location
- Pennsylvania · United States of America
Registrant
- Firm
- INOVIO PHARMACEUTICALS, INC.
- Location
- Plymouth Meeting, Pennsylvania, United States of America
Lobbying activities
1 issueHealth Issues
Issues related to COVID-19 research and development, vaccine distribution and manufacturing; Next Generation COVID-19 vaccines and boosters; Issues related to ASPR/BARDA and manufacturing of COVID-10 vaccines and boosters; Issues related to Oncology and HPV cancers; Continuing Resolution (CR), H.R. 6833, the Continuing Resolution and Ukraine Supplemental Appropriations Act; FY2023 Omnibus Appropriations Act, H.R. 2617; Issues related to the Prescription Drug User Fee Act (PDUFA); Issues related to the Medical Device User Fees Amendment (MDUFA IV); ARPA-H Act, H.R 5585; Accelerated Approval Integrity Act of 2022, H.R. 6963; Prevent Pandemic Act, S. 3799; DNA Medicines awareness
Lobbyistsms COOKAB HASHEMI
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)